Devices › Bronchoscope (flexible or rigid)
Device brand name · Bronchovideoscope
Evis Lucera Elite Bronchovideoscope: medical device reports filed with FDA
5,881 reports name it, 2019–2026. Manufacturer given most often on reports: Aizu Olympus. Product code EOQ.
- 5,881
- device reports naming the brand
- 0% of all MAUDE reports · about 894 a year
- 2,352
- reports, 12 months to August 2026
- 1,409 in the 12 months before
- 98.6%
- classified as malfunction
- 86% across the product code
- 0%
- classified as death, as reported
- 1 reports · not verified by FDA
5,881 medical device reports received by FDA name the brand "Evis Lucera Elite Bronchovideoscope" (bronchovideoscope); the manufacturer given most often on reports is Aizu Olympus; received from December 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
2,352 reports arrived in the 12 months to August 2026, up 67% from 1,409 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (98.6%) and injury (1.4%); across all bronchoscope (flexible or rigid) reports (product code EOQ) death is recorded in 0.6% and malfunction in 86%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are no display/image (40.1%), communication or transmission problem (21.1%) and erratic or intermittent display (11%). The patient problems coded most often are hemorrhage/blood loss/bleeding, pneumothorax and foreign body in patient. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 32,212 reports carrying product code EOQ. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| No display/image | 2,360 | 40.1% | 23.1% |
| Communication or transmission problemthe device could not communicate or transmit | 1,239 | 21.1% | 10.7% |
| Erratic or intermittent display | 648 | 11% | 5.1% |
| Poor quality image | 545 | 9.3% | 4.5% |
| Peeled/delaminated | 382 | 6.5% | 8.7% |
| Thermal decomposition of device | 198 | 3.4% | 3.7% |
| Breakthe device broke | 139 | 2.4% | 8.2% |
| Display or visual feedback problem | 118 | 2% | 1.5% |
| Corrodedthe device corroded | 116 | 2% | 2% |
| Degraded | 108 | 1.8% | 1.9% |
| Detachment of device or device componentpart of the device came off | 105 | 1.8% | 4.6% |
| Failure to clean adequately | 105 | 1.8% | 2.5% |
| Flare or flash | 89 | 1.5% | 0.5% |
| Connection problema connection problem | 70 | 1.2% | 0.5% |
| Device reprocessing problem | 64 | 1.1% | 2% |
| Image display error/artifact | 61 | 1% | 0.7% |
| Material deformation | 43 | 0.7% | 1% |
| Gas/air leak | 39 | 0.7% | 0.4% |
| Residue after decontamination | 34 | 0.6% | 0.3% |
| Melted | 31 | 0.5% | 0.9% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Hemorrhage/blood loss/bleeding | 17 | 0.3% |
| Pneumothoraxa collapsed lung | 14 | 0.2% |
| Foreign body in patientpart of a device left in the patient | 6 | 0.1% |
| Pneumonialung infection | 6 | 0.1% |
| Low oxygen saturation | 5 | 0.1% |
| Respiratory tract infectiona respiratory infection | 5 | 0.1% |
| Air embolism | 2 | 0% |
| Bacterial infectiona bacterial infection | 2 | 0% |
| Dyspneashortness of breath | 2 | 0% |
| Fever | 2 | 0% |
| Hemoptysis | 2 | 0% |
| High blood pressure/ hypertension | 2 | 0% |
| Pleural effusionfluid around the lung | 2 | 0% |
| Respiratory failurethe lungs could not supply enough oxygen | 2 | 0% |
| Respiratory insufficiency | 2 | 0% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Evis Lucera Elite Bronchovideoscope | Product code EOQ | All MAUDE reports |
|---|---|---|---|
| Reports | 5,881 | 32,212 | 26,136,888 |
| Share of that pool | — | 18.3% | 0% |
| Classified as death, per 1,000 reports | 0 | 6 | 9 |
| Classified as injury | 1.4% | 13% | 36.2% |
| Classified as malfunction | 98.6% | 86% | 62.3% |
| Filed by the manufacturer | 100% | 97.8% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code EOQ
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Bronchovideoscope | 1,924 | 938 | 0.1% |
| Ion | 2,687 | 499 | 8.2% |
| Evis Lucera Bronchovideoscope | 1,596 | 407 | 0.1% |
| Tracheal Intubation Fiberscope | 1,169 | 324 | 0% |
| Oes Bronchofiberscope | 487 | 112 | 0% |
| Airway Mobilescope | 430 | 182 | 0% |
| Evis Lucera Bronchofibervideoscope | 351 | 71 | 0% |
| Bronchofiberscope | 322 | 126 | 0.3% |
| SINGLE USE BIOPSY VALVE (Sterile) | 293 | 130 | 0% |
| Single Use Suction Valve Sterile | 282 | 0 | 0% |
| Evis Exeraii Bronchovideoscope | 252 | 0 | 0.8% |
| Evis Exera Bronchovideoscope | 244 | 34 | 4.5% |
| Visera Tracheal Intubation Videoscope | 157 | 67 | 0% |
| Halogen Light Source | 459 | 55 | 0% |
| Olympus | 2,240 | 9 | 2.5% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Evis Lucera Elite Bronchovideoscope reports
How many FDA reports name Evis Lucera Elite Bronchovideoscope?
5,881 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 2,352 in the latest 12 months.
What kinds of events are reported?
malfunction (98.6%) and injury (1.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
no display/image (40.1%), communication or transmission problem (21.1%), erratic or intermittent display (11%), poor quality image (9.3%) and peeled/delaminated (6.5%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Evis Lucera Elite Bronchovideoscope was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.